Elevance Health, Inc.

Elevance Health’s 2026 10-Q presents a picture of robust cash generation from operations. Net cash provided by operating activities — cash generated from core business operations — increased significantly, from $1,017 million in the first three months of 2025 to $4,332 million for the same period in 2026, a change of $3,315 million. The Management’s Discussion and Analysis (MD&A) section, Item 7, directs readers to specific notes for a deeper dive into the company’s sources and uses of capital, including investments, derivative financial instruments, debt, and its capital stock program.

The filing does not provide values for several key forensic metrics, limiting a quantitative assessment of potential accounting risk or fundamental strength. Beneish’s 1999 eight-ratio earnings-manipulation detector, the M-Score, is not available. Similarly, Altman’s 1968 bankruptcy-distress index, the Z″, is absent. Piotroski’s 2000 9-point fundamental strength scan, the F-Score, also remains uncalculated for this filing. Finally, the Fog Index — a readability score where 12 equals a newspaper and 18+ suggests obfuscation — is not provided, making it impossible to assess the document’s textual clarity.

The MD&A emphasizes liquidity, referring to a summary of major cash sources and uses. The balance sheet, Item 1, shows cash and cash equivalents increased from $9,491 million at December 31, 2025, to $9,657 million by March 31, 2026. Premium receivables, net — amounts owed to the company for insurance premiums — also rose from $10,073 million to $11,525 million over the same period. The risk factors section, Item 1A, lists titles such as “UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS” and “DEFAULTS UPON SENIOR SECURITIES,” indicating areas of potential concern that would require further investigation if their specific content were provided.

This filing provides a snapshot of Elevance Health’s financial condition and operational cash flow for the quarter. What it does not provide, due to the absence of calculated forensic scores, is an immediate red flag or strong signal regarding potential earnings manipulation, bankruptcy risk, or fundamental strength. The lack of detailed risk factor content also limits insight into specific operational or financial threats. Consequently, this reading cannot offer a view on whether the security is mispriced, only that the reported cash generation is substantial. Read the 10-Q. Decide for yourself.